UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 984

Sortiert nach

Development of a therapeutic drug‐monitoring algorithm for outpatients receiving voriconazole: A multicentre retrospective study

British journal of clinical pharmacology, 2024-05, Vol.90 (5), p.1222-1230

2024

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients

British journal of clinical pharmacology, 2018-07, Vol.84 (7), p.1587-1597

2018

Link zum Volltext

Verfügbarkeit prüfen

Autoinhibitory properties of the parent but not of the N‐oxide metabolite contribute to infusion rate‐dependent voriconazole pharmacokinetics

British journal of clinical pharmacology, 2017-09, Vol.83 (9), p.1954-1965

2017

Link zum Volltext

Verfügbarkeit prüfen

Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults

Clinical pharmacology and therapeutics, 2018-11, Vol.104 (5), p.957-965

2018

Link zum Volltext

Verfügbarkeit prüfen

EFFICACY OF INTRABRONCHIAL VORICONAZOLE INSTILLATION FOR INOPERABLE PULMONARY ASPERGILLOMA: A RANDOMIZEDCONTROLLED TRIAL

Respirology (Carlton, Vic.), 2019-11, Vol.24 (S2), p.71-71

2019

Link zum Volltext

Verfügbarkeit prüfen

Using Child‐Pugh Class to Optimize Voriconazole Dosage Regimens and Improve Safety in Patients with Liver Cirrhosis: Insights from a Population Pharmacokinetic Model‐based Analysis

Pharmacotherapy, 2021-02, Vol.41 (2), p.172-183

2021

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Clinical microbiology and infection, 2018-05, Vol.24, p.e1-e38

2018

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels

Medical mycology (Oxford), 2016-05, Vol.54 (4), p.353-360

2016

Link zum Volltext

Verfügbarkeit prüfen

Inflammation is a potential risk factor of voriconazole overdose in hematological patients

Fundamental & clinical pharmacology, 2019-04, Vol.33 (2), p.232-238

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy

Clinical pharmacology and therapeutics, 2017-07, Vol.102 (1), p.45-51

2017

Link zum Volltext

Verfügbarkeit prüfen

COVID‐19 associated pulmonary aspergillosis

Mycoses, 2020-06, Vol.63 (6), p.528-534

2020

Link zum Volltext

Verfügbarkeit prüfen

Tacrolimus blood concentration increase depends on administration route when combined with voriconazole in pediatric stem cell transplant recipients

Pediatric transplantation, 2020-02, Vol.24 (1), p.e13619-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Hypokalemia and Hyponatremia in Adult Patients Receiving Voriconazole Therapeutic Drug Monitoring

Journal of clinical pharmacology, 2024-04, Vol.64 (4), p.461-468

2024

Link zum Volltext

Verfügbarkeit prüfen

Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Voriconazole After Single and Multiple Doses in Healthy Volunteers

Journal of clinical pharmacology, 2012-02, Vol.52 (2), p.195-203

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinically relevant bidirectional drug‐drug interaction between midostaurin and voriconazole

British journal of clinical pharmacology, 2023-07, Vol.89 (7), p.2304-2308

2023

Link zum Volltext

Verfügbarkeit prüfen

Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome

Cancer, 2024-06, Vol.130 (11), p.1964-1971

2024

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment

Mycoses, 2016-10, Vol.59 (10), p.644-651

2016

Link zum Volltext

Verfügbarkeit prüfen

Adverse effects of voriconazole: Over a decade of use

Clinical transplantation, 2016-11, Vol.30 (11), p.1377-1386

2016

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?

Medical mycology (Oxford), 2018-04, Vol.56 (3), p.263-278

2018

Link zum Volltext

Verfügbarkeit prüfen

Moderate correlation between systemic IL‐6 responses and CRP with trough concentrations of voriconazole

British journal of clinical pharmacology, 2018-09, Vol.84 (9), p.1980-1988

2018

Link zum Volltext

Verfügbarkeit prüfen

VARIABILITY OF VORICONAZOLE SERUM CONCENTRATIONS IN PATIENTS WITH CHRONIC PULMONARY ASPERGILLOSIS

Respirology (Carlton, Vic.), 2017-11, Vol.22 (S3), p.210-210

2017

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetic model‐guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction

Pharmacotherapy, 2022-01, Vol.42 (1), p.23-33

2022

Link zum Volltext

Verfügbarkeit prüfen

A retrospective, multicenter study of voriconazole trough concentrations and safety in patients with Child‐Pugh class C cirrhosis

Journal of clinical pharmacy and therapeutics, 2018-12, Vol.43 (6), p.849-854

2018

Link zum Volltext

Verfügbarkeit prüfen

Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021

Internal medicine journal, 2021-11, Vol.51 (S7), p.143-176

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 984

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

KollektionWiley Online Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(918)
Mit Volltextzugriff
(955)

Publikationsform

Artikel
(926)
Berichte
(58)

Sprache

Englisch
(972)
Japanisch
(117)
Deutsch
(96)

Erscheinungsjahr

n.n

Thema

Voriconazole
(873)
Science & Technology
(860)
Life Sciences & Biomedicine
(857)
Humans
(657)
Mycology
(362)
Antifungal Agents - Therapeutic Use
(344)
Male
(340)
Female
(286)
Dermatology
(285)
Infectious Diseases
(276)
Middle Aged
(234)
Adult
(206)
Antifungal Agents - Pharmacology
(196)
Triazoles - Therapeutic Use
(189)
Pyrimidines - Therapeutic Use
(162)
Aged
(156)
Microbial Sensitivity Tests
(153)
Pharmacology & Pharmacy
(140)
Itraconazole
(139)
Antifungal Agents - Administration & Dosage
(136)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Development of a therapeutic drug‐monitoring algorithm for outpatients receiving voriconazole: A multicentre retrospective study

Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients

Autoinhibitory properties of the parent but not of the N‐oxide metabolite contribute to infusion rate‐dependent voriconazole pharmacokinetics

Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults

EFFICACY OF INTRABRONCHIAL VORICONAZOLE INSTILLATION FOR INOPERABLE PULMONARY ASPERGILLOMA: A RANDOMIZEDCONTROLLED TRIAL

Using Child‐Pugh Class to Optimize Voriconazole Dosage Regimens and Improve Safety in Patients with Liver Cirrhosis: Insights from a Population Pharmacokinetic Model‐based Analysis

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms: A multicentre study conducted in Japan

Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels

Inflammation is a potential risk factor of voriconazole overdose in hematological patients

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy

COVID‐19 associated pulmonary aspergillosis

Tacrolimus blood concentration increase depends on administration route when combined with voriconazole in pediatric stem cell transplant recipients

Hypokalemia and Hyponatremia in Adult Patients Receiving Voriconazole Therapeutic Drug Monitoring

Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Voriconazole After Single and Multiple Doses in Healthy Volunteers

Clinically relevant bidirectional drug‐drug interaction between midostaurin and voriconazole

Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome

Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment

Adverse effects of voriconazole: Over a decade of use

Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?

Moderate correlation between systemic IL‐6 responses and CRP with trough concentrations of voriconazole

VARIABILITY OF VORICONAZOLE SERUM CONCENTRATIONS IN PATIENTS WITH CHRONIC PULMONARY ASPERGILLOSIS

Population pharmacokinetic model‐guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction

A retrospective, multicenter study of voriconazole trough concentrations and safety in patients with Child‐Pugh class C cirrhosis

Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021

Aktive Filter

Suchergebnisse filtern